Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Wiley: New York, 1977
Software: HSK
Contraindications: Active uveal inflammation Most cases of angle-closure glaucoma , due to the possibility of increasing angle block Hypersensitivity to the active or inactive ingredients Side Effects: Retinal detachment has been reported in a few cases Stinging, burning, lacrimation Iris cysts may form Lens opacities Cardiac irregularities Pharmacokinetics: Administered in eye drops to patients with glaucoma ) Forms an irreversible covalent bond with the ACh binding site on cholinesterase (duration of action is ~100 hrs Drug Interactions: Potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides Patients undergoing systemic anticholinesterase treatment should be warned of the possible additive effects References: Merck Manual Professional Edition (2026): Medications Used to Treat Glaucoma
Clinically, GHK-Cu has been shown to: Stimulate collagen and glycosaminoglycan synthesis in skin fibroblasts Promote angiogenesis (new blood vessel formation) Attract immune cells to accelerate wound healing Provide antioxidant and anti-inflammatory effects Modulate gene expression to reverse cells to a healthier, more youthful state Its cosmetic and therapeutic uses span anti-aging skincare, scar reduction, wound healing, and hair regrowth
ATSAS 2.8: a comprehensive data analysis suite for small-angle scattering from macromolecular solutions
